Related Experiment Video
Updated: Jun 5, 2026
07:43
Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons
Published on: January 7, 2019
Transforming growth factor-β signaling in motor neuron diseases
1Department of Neurology, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya, Japan. ka2no@med.nagoya-u.ac.jp
Current Molecular Medicine
|December 30, 2010
Summary
Transforming growth factor beta (TGF-β) signaling protects neurons and influences glial cells, offering a potential therapeutic strategy for motor neuron diseases like ALS.
Area of Science:
- Neuroscience
- Molecular Biology
- Cell Biology
Background:
- Transforming growth factor beta (TGF-β) is a cytokine regulating cellular functions, with isoforms expressed in the central nervous system.
- TGF-β signaling protects neurons from excitotoxicity, a key factor in neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS).
Purpose of the Study:
- To investigate the role of TGF-β signaling in the pathogenesis of motor neuron diseases.
- To explore TGF-β signaling as a potential therapeutic target for neurodegenerative disorders.
Main Methods:
- Review of existing literature on TGF-β signaling in neurodegeneration.
- Analysis of studies involving TGF-β-Smad2/3 pathway in ALS mouse models.
- Examination of TGF-β superfamily members like myostatin and BMP in neuromuscular disorders.
Main Results:
- The TGF-β-Smad2/3 pathway has shown potential in restoring motor function in ALS models.
- Disruption of TGF-β signaling is linked to motor neuron damage in spinal and bulbar muscular atrophy.
- Members of the TGF-β superfamily, such as myostatin and BMP, are implicated in neuromuscular junction regulation and disease.
Conclusions:
- Disruption of TGF-β signaling is a significant factor in the development of motor neuron diseases.
- Modulating TGF-β signaling presents a promising therapeutic avenue for treating motor neuron diseases.
Related Concept Videos
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:00Enzyme-linked Receptors
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...